Northwest Biotherapeutics, Inc. (NWBO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov15

Northwest Biotherapeutics, Inc. released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 706 K and EPS of USD -0.0455

04:00

Northwest Biotherapeutics, Inc. released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 200K, actual EPS USD -0.02

04:00

Aug15

Northwest Biotherapeutics, Inc. released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 506K, actual EPS USD -0.0254

03:00

Northwest Biotherapeutics, Inc. released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 131 K, actual EPS USD -0.0103

03:00

May16

Northwest Biotherapeutics, Inc. released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 375K, actual EPS USD -0.0144

03:00

Apr1

Northwest Biotherapeutics, Inc. released FY2024 annual earnings on March 31 (EST), actual revenue 1.382 M USD, actual EPS -0.07 USD

03:00

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 200 K, Net Income -27.18 M, EPS -0.02

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 131 K, Net Income -15.94 M, EPS -0.011

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 375 K, Net Income -19.61 M, EPS -0.0144

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More